🇺🇸 FDA
Patent

US 12151062

Compositions and devices to administer pharmaceutical compositions nasally

granted A61KA61K31/4184A61K47/32

Quick answer

US patent 12151062 (Compositions and devices to administer pharmaceutical compositions nasally) held by The Board of Regents of the University of Texas System expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/4184, A61K47/32, A61K49/0043, A61K49/06